TIPE2 and neoplasm: Concerning the recurrence and mortality rate, low rates of recurrence and patient mortality were associated with high TIPE2 immunostaining, which suggests that the presence of TIPE2-positive immunostaining has a good prognostic impact on UC patients protecting against tumor relapses and mortality.